37.62
Schlusskurs vom Vortag:
$38.33
Offen:
$38.3
24-Stunden-Volumen:
387.93K
Relative Volume:
0.80
Marktkapitalisierung:
$1.87B
Einnahmen:
$3.18B
Nettoeinkommen (Verlust:
$24.08M
KGV:
82.48
EPS:
0.4561
Netto-Cashflow:
$104.49M
1W Leistung:
-0.61%
1M Leistung:
+7.44%
6M Leistung:
+63.28%
1J Leistung:
+54.31%
Astrana Health Inc Stock (ASTH) Company Profile
Firmenname
Astrana Health Inc
Sektor
Branche
Telefon
(626) 282-0288
Adresse
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ASTH
Astrana Health Inc
|
37.62 | 1.90B | 3.18B | 24.08M | 104.49M | 0.4561 |
|
HCA
Hca Healthcare Inc
|
378.54 | 85.27B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
175.32 | 14.92B | 21.46B | 2.65B | 3.35B | 19.23 |
|
DVA
Davita Inc
|
194.36 | 12.65B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
21.57 | 11.62B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
105.85 | 10.45B | 6.07B | 793.80M | 464.40M | 5.9914 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Eingeleitet | Needham | Buy |
| 2025-04-01 | Eingeleitet | Barclays | Equal Weight |
| 2024-10-14 | Eingeleitet | TD Cowen | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-07-11 | Hochstufung | Truist | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-26 | Eingeleitet | Jefferies | Buy |
| 2024-02-22 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-01-24 | Eingeleitet | Stifel | Buy |
| 2023-12-22 | Eingeleitet | Truist | Hold |
| 2023-10-17 | Eingeleitet | BTIG Research | Buy |
| 2023-04-12 | Eingeleitet | BofA Securities | Neutral |
| 2022-12-19 | Eingeleitet | Lake Street | Buy |
| 2022-09-21 | Eingeleitet | William Blair | Outperform |
| 2022-01-11 | Fortgesetzt | Colliers Securities | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Astrana Health Inc Aktie (ASTH) Neueste Nachrichten
Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates - MSN
Astrana Health names George Christides interim medical director By Investing.com - Investing.com Nigeria
Astrana Health (ASTH) price target increased by 18.07% to 44.43 - MSN
Astrana Health Raised to Overweight From Equal-Weight by Barclays - Moomoo
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack - Yahoo Finance
ASTH Stock Price, Quote & Chart | ASTRANA HEALTH INC (NASDAQ:ASTH) - ChartMill
Astrana Health Q1 2026 slides: 56% revenue growth, full-risk shift accelerates - Investing.com Nigeria
Astrana Health closes deal with Prospect Health at a lower price - MSN
Does Astrana’s AI Partnership With California Physicians Reshape the Bull Case for Astrana Health (ASTH)? - Sahm
A Look at Astrana Health Inc (ASTH) After 3.5% Decline -- GF Val - GuruFocus
Cash-Rich Stocks: Appian and Array Face Challenges, Astrana Health ShinesNews and Statistics - IndexBox
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)? - Yahoo Finance
A Look At Astrana Health (ASTH) Valuation After Q1 Earnings And AI Driven Full Risk Expansion - Sahm
52-Week High Stocks: Sell EchoStar, Watch Vita Coco and Astrana HealthNews and Statistics - IndexBox
Astrana Health (ASTH) COO and CFO surrenders 8,155 shares for tax withholding - Stock Titan
Astrana Health partners with California physician group By Investing.com - Investing.com Nigeria
Astrana Health says Prospect deal is ahead of schedule as Q1 trends beat expectations - MSN
Astrana Health Q1 2026 Results: Revenue Beat and AI-Driven Growth - IndexBox
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call - Yahoo Finance
Will Strong Q1 Results and New Leadership Shift Astrana Health's (ASTH) Value-Based Care Narrative - simplywall.st
Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Bristol-Myers Squibb (BMY) and Progyny (PGNY) - The Globe and Mail
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $47 - Moomoo
Truist raises Astrana Health stock price target to $47 on outlook - Investing.com UK
Truist raises Astrana Health stock price target to $47 on outlook By Investing.com - Investing.com South Africa
BofA Securities Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
Astrana Health Updates Investor Presentation via Regulation FD Disclosure - The Globe and Mail
Astrana Health Inc.Common Stock (NQ: ASTH - FinancialContent
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations - Inkl
Astrana Health names George Christides interim medical director - Investing.com UK
ASTH Q1 Deep Dive: AI-Enabled Platform, Full-Risk Expansion, and Operating Leverage Shape Results - Yahoo Finance
Astrana Health announces appointment of interim national medical director - marketscreener.com
Astrana Health, Inc. Announces Appointment of Interim National Medical Director - PR Newswire
Astrana outlines $3.8B-$4.1B 2026 revenue outlook as net leverage targets at or below 2x - MSN
Astrana Health Announces Upcoming Chief Medical Officer Resignation - TipRanks
Astrana Health chief medical officer Dinesh Kumar to resign effective June 1 - Investing.com
Astrana Health chief medical officer Dinesh Kumar to resign effective June 1 By Investing.com - Investing.com South Africa
Astrana Health (NASDAQ: ASTH) CMO Dinesh Kumar plans June 1, 2026 exit - Stock Titan
Astrana Health (NASDAQ: ASTH) posts updated May 2026 investor presentation - Stock Titan
Astrana Health partners with California physician group - Investing.com UK
Astrana Health : Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care - marketscreener.com
Finanzdaten der Astrana Health Inc-Aktie (ASTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):